Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 7NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Glioblastoma 18Carcinoma, Non-Small-Cell Lung 6Glioma 5Brain Neoplasms 5Head and Neck Neoplasms 4Neoplasms 3Neoplasm Metastasis 3Melanoma 3Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Astrocytoma 3Stomach Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Pain 2Lung Neoplasms 2Gliosarcoma 2Central Nervous System Neoplasms 2Bone Neoplasms 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomatitis 1Small Cell Lung Carcinoma 1Sarcoma, Synovial 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors 1Nervous System Diseases 1Neoplasms by Site 1

Interventions

pembrolizumab 44Paclitaxel 37Carboplatin 30Doxorubicin 11Cisplatin 11Bevacizumab 11lenvatinib 9Nivolumab 9Docetaxel 9Fulvestrant 8Gemcitabine 7Oxaliplatin 6Fluorouracil 6Pemetrexed 5Letrozole 5Ipilimumab 5Cetuximab 5spartalizumab 4selinexor 4dostarlimab 4Trastuzumab 4Irinotecan 4trastuzumab deruxtecan 3tisotumab vedotin 3serabelisib 3sacituzumab govitecan 3ribociclib 3olaparib 3epacadostat 3durvalumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Endometrial Neoplasms × Radiation × Clear all
NCT01045187 2012-08-01

Feasibility Study Using the Xoft System for the Treatment of Endometrial Cancer

Xoft, Inc.

Phase NA Completed
15 enrolled 5 charts
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡